Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) occurs in up to 15% of patients with cystic fibrosis (CF) ([1]). Clinically, the disease manifests by symptoms consistent with bronchial asthma along ...